Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of January 2026
Apple Boston @Apple Boston
Brass member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,008,952talents

Virtual portfolio value:

$5,104,400talents

Net overall return per annum:

19.72%

AYA current rank order:

#15

Asset investment philosophy:
Apple Boston trades U.S. stocks with the top #226 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
UBXG U-BX Technology Ltd. Ordinary Shares $0.34 $3.98 38,608 +1,070.59% $140,533
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 7,019 +901.60% $118,340
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 80,273 +793.33% $95,525
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 11,933 +2,108.33% $90,571
VATE INNOVATE Corp. Common Stock $0.53 $4.14 22,718 +681.13% $82,012
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 629 +601.88% $70,379
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,509 +589.24% $61,975
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 640 +500.61% $52,576
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 90,033 +475.00% $51,319
MRNS Marinus Pharmaceuticals Inc. Common Stock $1.94 $11.62 3,749 +498.97% $36,290
Sum $799,520

Top 20 influencers

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$NVDA $AAPL
$TSLA $META
$GOOG
$AMZN
$MSFT

Blog+More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

Daisy Harvey

2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic

+See More

Tony Robbins recommends portfolio optimization only once a year.

Laura Hermes

2017-02-19 07:41:00 Sunday ET

Tony Robbins recommends portfolio optimization only once a year.

In his recent book on personal finance, Tony Robbins recommends that each investor should rebalance his or her investment portfolio *only once a year* to in

+See More

President Trump supports a bipartisan bill or the Foreign Investment Risk Review Modernization Act.

Charlene Vos

2018-07-21 13:35:00 Saturday ET

President Trump supports a bipartisan bill or the Foreign Investment Risk Review Modernization Act.

President Trump supports a bipartisan bill or the Foreign Investment Risk Review Modernization Act (FIRRMA), which effectively broadens the jurisdiction of

+See More

The U.S. federal government debt has risen from less than 40% of total GDP about a decade ago to 78% as of May 2018.

John Fourier

2018-06-01 07:30:00 Friday ET

The U.S. federal government debt has risen from less than 40% of total GDP about a decade ago to 78% as of May 2018.

The U.S. federal government debt has risen from less than 40% of total GDP about a decade ago to 78% as of May 2018. The Congressional Budget Office predict

+See More

Innovative investment theory and practice

Olivia London

2022-05-15 10:29:00 Sunday ET

Innovative investment theory and practice

Innovative investment theory and practice Corporate investment can be in the form of real tangible investment or intangible investment. The former conce

+See More